Covered recipient · General Payments record
JESSICA MERRITT
Allopathic & Osteopathic Physicians Psychiatry & Neurology Child & Adolescent Psychiatry
General Payments · PY2020–2024
$177.15
- Reported across 9 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $164.06 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alkermes, Inc. | $45.76 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $42.44 | 2 |
| Noven Therapeutics, LLC | $23.58 | 1 |
| ITI, Inc. | $19.34 | 1 |
| Noven Pharmaceuticals, Inc. | $19.17 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $13.77 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alkermes, Inc. | $24.06 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120554000 | CMS |
| Alkermes, Inc. | $21.70 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120554002 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $13.77 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146781440 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19.34 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143277601 | CMS |
| Noven Pharmaceuticals, Inc. | $19.17 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084816810 | CMS |
| Noven Therapeutics, LLC | $23.58 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084821803 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.13 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137635234 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.31 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137635236 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2024
- Source files
- Dataset page · Bulk file · PY2020 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.